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Figure 1. A complex network of many signal transduction pathways
determines the development of either transient or permanent cartilage.
ECHO consists of 123 nodes with 354 interactions. We can perform in
silico experiments using the complete network, or investigate detailed
processes in smaller areas of the network.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S157indicates that knockdown of DKK1 alone is not sufficient to result in
hypertrophic differentiation of articular chondrocytes.
After addition of 10 ng/ml IL-1b DKK1 and FRZB mRNA levels were
decreased while expression of GREM1 mRNA was increased (figure 1).
IL-1b is a potent activator of MMP expression in human chondrocytes
and has been implicated in cartilage degradation in OA. As expected, IL-
1b potently induced expression of MMP1, MMP3, and MMP13 at the
mRNA level. Co-stimulation with IL-1b and DKK1 or GREM1 further
increased IL-1b-induced MMP expression. Especially MMP3 was
increased significantly. Surprisingly, the addition of DKK1, FRZB and
GREM1 simultaneously in the presence of IL-1b reduced MMP gene
expression to undetectable levels (figure 2). This suggests that the
combination of three antagonists can effectively counteract IL-1b
induced catabolic activity in human chondrocytes.
Conclusions: Hypertrophic differentiation may play a role in early and
late stage OA. Inhibition of hypertrophy by DKK1, FRZB and GREM1
might be a therapeutic target to slow down further OA progression.
DKK1 plays a crucial part in preventing chondrocytes from hypertrophy.
Furthermore, we found that the expression of DKK1, FRZB, GREM1 in
human primary chondrocytes was affected by the osteoarthritis asso-
ciated factor IL-1b. We also provided evidence that, even in the presence
of IL-1b, the combination of three antagonists completely inhibited the
expression of genes associated with chondrocyte hypertrophy and OA.
Figure 1. Effects of IL1b on the mRNA expression of DKK1, FRZB, GREM1.
Human chondrocytes received a single dose of 10ng/ml IL-1b. Antagonists
mRNA expression was measured by qRT-PCR. * P < 0.05. Student T-test.
Figure 2. Chondrocytes in monolayer cultures were exposed to 10ng/ml of
recombinant human IL-1b, and 200ng/ml each of DKK1, FRZB, GREM1 for
48 hours. MMP expression was measured by qRT-PCR.
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NetherlandsPurpose: Computational modeling of biological networks permits
comprehensive analysis of cells and tissues to define molecular phe-
notypes and novel hypotheses. We recently presented ANIMO (Analysis
of Networks with Interactive Modeling), an intuitive software tool for
modeling molecular networks for use by biologists. We used ANIMO to
generate a computational model of articular cartilage, ECHO.
Over 1.5 million people in the Netherlands suffer from osteoarthritis
(OA) in one or more joints. OA is a painful, disabling disease and cur-
rently cannot be cured. In a subset of OA patients, joint cartilage is
replaced by bone via endochondral ossification. This is a natural process
in growing long bones, where transient growth plate cartilage is
replaced by bone. In contrast, healthy joint cartilage is permanent as it is
protected against bone formation. Stable joint cartilage is under control
of master transcription factor SOX9, whereas bone formation is con-
trolled by RUNX2. The processes that regulate the switch between a
SOX9þ state and a RUNXþ state are poorly understood, which greatly
hampers the development of successful therapies.
Methods: Based on a large-scale literature study and our own experi-
ments, we recently developed ECHO (Executable Chondrocyte), a com-
putational model of the key processes that regulate expression and
activity of SOX9 and RUNX2. Simulations in ECHO were performed to
investigate the robustness of the chondrocyte network.
To validate ECHO predictions, we used FRAP to measure mobility of SOX9
andRUNX2,whichwehave shown to be a faithful readout of their activity.
Primary chondrocytes of 2 OA donors were tested at passage 2 after
isolation. In these donors we observed little interdonor variation in
SOX9 mobility. Using lipofectamine LTX we obtained 40-70% trans-
fection efficiencies in primary human chondrocytes even at low
passages.
Results: In its unperturbed form, ECHO displays two stable states in
which activities of SOX9 and RUNX2 are mutually exclusive. We tested
the hypothesis that addition of WNT (performed with a few mouse
clicks) will change permanent into transient cartilage by inducing
hypertrophy. Indeed, when we add WNT, a known regulator of bone
formation, the permanent or SOX9þ state changes to a transient or
RUNX2þ state. However, it is known that healthy articular cartilage is
resistant to hypertrophic differentiation. Our group has previously
found that this was probably due to the secretion of DKK1, FRZB and
GREM1. We therefore added nodes to ECHO representing DKK1, FRZB
and GREM1 (figure 1). GREM1 and DKK1 are able to stabilize the per-
manent cartilage or SOX9þ state even after addition of WNT to ECHO.
We observed that in our model activation ofWNT leads to a switch from
a SOX9þ state to a RUNX2þ state. To prove that WNT/b-catenin sig-
naling can directly regulate SOX9 function, we investigated the
response of SOX9 mobility to WNT3A in live primary chondrocytes.
Addition of WNT3A to human chondrocytes transfected with SOX9-GFP
resulted in a significant decrease of the immobile SOX9 fraction from
53% to 34% within 15 minutes after addition. A direct correlation
between the elevated levels of b-catenin after WNT addition and the
activity of SOX9 indicates that b-catenin can directly change the
mobility by complex formation with SOX9.
Conclusions: Using ECHO we predicted the stimuli that prevents
hypertrophic differentiation differentiation of articular cartilage, and
tested this experimentally with FRAP using SOX9 and RUNX2 mobility
as a read-out.
